Lexicon Pharmaceuticals, Inc.
USD2.64
+0.09 (+3.53%)
CEO
Michael S. Exton
IPO Date
2000-04-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.55
Prev. Close
$2.55
Day Low
$2.48
Day High
$2.66
52W Low
$0.80
52W High
$2.67
Market Cap
$1.17B
Volume
4.62M
| -1.2 |
| 31 Dec 2023 | FY | -4798.0% | -14710.9% | -190.2% | -77.2% | 1.14 | 5.60 | -1.9 |
| 31 Dec 2022 | FY | -37681.3% | -73341.0% | -87.0% | -52.5% | 0.47 | 6.08 | -3.1 |
| 31 Dec 2021 | FY | -18371.8% | -29449.0% | -77.3% | -64.1% | 0.02 | 4.02 | -6.5 |
| 31 Dec 2020 | FY | 92.0% | -244.1% | -37.5% | -28.7% | 0.08 | 3.37 | -6.5 |
| 31 Dec 2019 | FY | 99.0% | 40.4% | 111.1% | 31.2% | 2.11 | 5.17 | 3.4 |
| 31 Dec 2018 | FY | 96.1% | -190.7% | 8.2% | -42.4% | -0.17 | 4.72 | -5.8 |
| 31 Dec 2017 | FY | 97.9% | -142.9% | -247.7% | -29.6% | 4.72 | 2.59 | -8.0 |
| 31 Dec 2016 | FY | -96.8% | -169.7% | -89.9% | -29.7% | 0.64 | 2.17 | -10.2 |
| -6.7 |
| 30 Sept 2025 | Q3 | 99.9% | -90.0% | -10.6% | -6.2% | 0.48 | 5.64 | -9.6 |
| 30 Jun 2025 | Q2 | 99.3% | 11.3% | 2.5% | 1.4% | 0.44 | 4.16 | 26.4 |
| 31 Mar 2025 | Q1 | 97.6% | -2004.4% | -20.6% | -8.5% | 0.83 | 2.22 | -1.6 |
| 31 Dec 2024 | Q4 | 2.3% | -127.2% | -23.1% | -11.3% | 0.74 | 5.44 | -2.0 |
| 30 Sept 2024 | Q3 | 95.9% | -3703.5% | -36.3% | -20.2% | 0.57 | 7.45 | -2.2 |
| 30 Jun 2024 | Q2 | 89.9% | -3244.0% | -22.3% | -14.3% | 0.44 | 11.51 | -2.4 |
| 31 Mar 2024 | Q1 | 84.5% | -4282.9% | -16.8% | -11.6% | 0.37 | 15.58 | -2.9 |
| 31 Dec 2023 | Q4 | -2012.8% | -7087.7% | -53.4% | -21.7% | 1.14 | 5.60 | -1.9 |